Loading clinical trials...
Loading clinical trials...
The main purpose of this study is to compare how one 50 mg tablet of SB-497115 is broken down in the body by healthy subjects versus subjects with mild, moderate or severe kidney problems. The study i...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
GlaxoSmithKline
NCT00908037 · Purpura, Thrombocytopaenic, Idiopathic
NCT01072162 · Purpura, Thrombocytopaenic, Idiopathic
NCT00351468 · Purpura, Thrombocytopaenic, Idiopathic
NCT01064336 · Purpura, Thrombocytopaenic, Idiopathic
NCT01098487 · Purpura, Thrombocytopaenic, Idiopathic
GSK Investigational Site
Gainesville, Florida
GSK Investigational Site
Saint Paul, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions